MyFinsight
Home
Blog
About
Contact
Download
Download image
Sale of fixed
maturity securities,...
$159,523K
Proceeds from issuance of
common stock and espp
$173K
Net cash provided by
investing activities
$107,501K
Net cash provided by
financing activities
$173K
Canceled cashflow
$52,022K
Net increase in
cash, cash...
$3,798K
Canceled cashflow
$103,876K
Acquisition of fixed
maturity securities,...
$51,174K
Acquisition of property and
equipment
$848K
Depreciation
$13,101K
Stock based
compensation
$6,840K
Impairment
$6,763K
Prepaid expenses and
other assets
-$2,342K
Non-cash operating lease
expense (benefit)
$1,912K
Accounts payable
$1,562K
Net cash used in
operating activities
-$103,876K
Canceled cashflow
$32,520K
Deferred revenue
-$109,164K
Net loss
-$9,580K
Operating lease liability
-$4,978K
Change in fair value of
contingent liabilities
$4,534K
Accrued expenses and
other liabilities
-$4,315K
Accretion of investments
$2,357K
Gain on reduction in
lease liability due to...
$1,395K
Deferred tax (benefit)
expense
-$73K
Back
Back
Cash Flow
source: myfinsight.com
Century Therapeutics, Inc. (IPSC)
Century Therapeutics, Inc. (IPSC)